IP Library › Granted Patent US 9,259,434
Granted Patent B2
US 9,259,434 · App. 13/942,982 · Granted Feb 16, 2016

Biopolymer system for tissue sealing

Inventors: Weiliam Chen (Mount Sinai, NY); John M. Abrahams (Scarsdale, NY)
Assignee: Endomedix, Inc.
A61K31/722A61K31/721A61K38/1875A61K47/48215A61K47/48784A61K48/00A61K49/0002A61K49/0457A61K51/1213A61L24/0031A61L24/043A61L24/08A61L24/104A61K9/0085A61K9/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,259,434
App. No.
13/942,982
Granted
Feb 16, 2016
Kind
B2
Abstract

A tissue sealant for use in surgical and medical procedures for sealing the tissues of a living mammal is provided. The tissue sealant comprises a hydrogel which is formed by gelation of a premix disposed on the tissue to be sealed. The premix comprises alkylated chitosan or a gelatin, and a polybasic carboxylic acid or an oxidized polysaccharide, in an aqueous medium. The premix can also include a dehydrating reagent, a carboxyl activating reagent, or both. A specific use of the tissue sealant is in the repair of the dura mater after brain surgery to prevent leakage of cerebrospinal fluid. The tissue sealant may include a therapeutic or protective agent such as an antibiotic or an anti-inflammatory drug.

Claims (7)

1. A biocompatible, biodegradable composition for use in sealing a biological tissue of a living mammal, the composition comprising a hydrogel, the hydrogel being produced by mixing a first solution comprising from about 1% to about 10% by weight of acrylated chitosan with a second solution comprising an oxidized polysaccharide, wherein the mixture, when applied to a biological tissue in need of sealing, forms a hydrogel within a minute after mixing thereby sealing the biological tissue.

2. The composition of claim 1 wherein the hydrogel is adapted to adhere to biological tissue of a living mammal, to adhesively seal the tissue.

3. The composition of claim 1 wherein the living mammal is a living human being.

4. The composition of claim 1 further comprising a therapeutic or protective agent.

5. The composition of claim 1 wherein the oxidized polysaccharide is oxidized dextran.

6. The composition of claim 5 , wherein the acrylated chitosan in the first solution has a degree of substitution of a chitosan backbone with acrylate groups in the range of from about 0.25 to about 0.45.

7. The composition of claim 1 , wherein the acrylated chitosan in the first solution has a degree of substitution of a chitosan backbone with acrylate groups in the range of from about 0.25 to about 0.45.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2015
From: CHEN, WEILIAM; ABRAHAMS, JOHN M.
To: ENDOMEDIX, INC.
Reel/Frame 036198/0920 →
Continuity (4)
Continuation 12882624 · Sep 15, 2010
Division 11530362 · Sep 8, 2006
Continuation In Part 11379182 · Apr 18, 2006
Related Publication 20140107065A1 · Apr 17, 2014